Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T12:50:48.695Z.
Calculation as of: 2026-10-06T12:50:48.695Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f9d3bab38235a1653807ee573cee89b2588007a5210257548b702658f8274e90
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
BioRestorative Therapies, Inc.
Market Cap
$3.09M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.09M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.48M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
